Abstract
Background: Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4] triazin-7(4H)-one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV.
Aims and Objectives: In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV.
Methods: In the present work, first time the molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas phase.
Results: The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies.
Conclusion: Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking, HOMO-LUMO.
Current Molecular Medicine
Title:Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Volume: 21 Issue: 8
Author(s): Siyamak Shahab and Masoome Sheikhi*
Affiliation:
- Independent Researcher, Gonbad-e-Kavoos,Iran
Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking, HOMO-LUMO.
Abstract:
Background: Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4] triazin-7(4H)-one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV.
Aims and Objectives: In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV.
Methods: In the present work, first time the molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas phase.
Results: The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies.
Conclusion: Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
Export Options
About this article
Cite this article as:
Shahab Siyamak and Sheikhi Masoome *, Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study, Current Molecular Medicine 2021; 21 (8) . https://dx.doi.org/10.2174/1566524020666200521075848
DOI https://dx.doi.org/10.2174/1566524020666200521075848 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Simple C-2-Substituted Quinolines and their Anticancer Activity
Letters in Drug Design & Discovery Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry Mild Carbohydrate Intolerance in Pregnancy
Current Diabetes Reviews Gene Electrotransfer to Skin; Review of Existing Literature and Clinical Perspectives
Current Gene Therapy Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template
Recent Patents on Anti-Cancer Drug Discovery Ecological Infectomics (Ecoinfectomics): Symbiotic Solutions to Microbial Infections
Anti-Infective Agents Diagnostic Stewardship in Times of COVID-19 Pandemic
Infectious Disorders - Drug Targets Withdrawal Notice: Predictive Time Series Analysis and Forecasting of COVID-19 Dataset
Recent Patents on Engineering The Contribution of Oxazolidinone Frame to The Biological Activity of Pharmaceutical Drugs and Natural Products
Mini-Reviews in Medicinal Chemistry Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics A New Nucleotide-composition Based Fingerprint of SARS-CoV with Visualization Analysis
Medicinal Chemistry Drug Repurposing: An Alternative Strategy to Treat COVID-19
Current Pharmaceutical Biotechnology The Impact of Crystallographic Data for the Development of Machine Learning Models to Predict Protein-Ligand Binding Affinity
Current Medicinal Chemistry Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Current Topics in Medicinal Chemistry Therapeutic Potentials of Black Seeds (<i>Nigella sativa</i>) in the Management of COVID-19 -A Review of Clinical and <i>In-silico</i> Studies
Anti-Infective Agents Recent Developments in the Medicinal Chemistry of Cannabimimetic Indoles, Pyrroles and Indenes
Current Medicinal Chemistry The Role of CO-RADS Scoring System in the Diagnosis of COVID-19 Infection and its Correlation with Clinical Signs
Current Medical Imaging A Cooperation Enforcement, Malice Detection and Energy Efficient Mechanism for Mobile Ad hoc Networks
International Journal of Sensors, Wireless Communications and Control Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?
Current Pharmaceutical Design